Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$44.56 - $62.43 $531,244 - $744,290
11,922 New
11,922 $538,000
Q1 2023

Dec 19, 2024

BUY
$49.5 - $65.92 $244,530 - $325,644
4,940 New
4,940 $264,000
Q1 2023

May 12, 2023

SELL
$49.5 - $65.92 $91,624 - $122,017
-1,851 Reduced 27.26%
4,940 $264,000
Q4 2022

Feb 13, 2023

SELL
$44.83 - $57.43 $82,935 - $106,245
-1,850 Reduced 21.41%
6,791 $363,000
Q3 2022

Nov 14, 2022

BUY
$46.07 - $60.1 $22,896 - $29,869
497 Added 6.1%
8,641 $398,000
Q2 2022

Aug 12, 2022

BUY
$55.0 - $70.47 $447,920 - $573,907
8,144 New
8,144 $448,000

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.38B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.